Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder.

The authors retrospectively examined the clinical outcome (after 1, 2 and 5 years of beginning the therapeutic protocols) for 16 rapid-cycling bipolar affective disorder patients given either lithium alone or lithium plus carbamazepine. The results suggest that both therapeutic protocols have been safe and clinically effective. However, improvement was observed earlier in the patients given lithium and carbamazepine.

RCT Entities:   Population Interventions Outcomes